Tuesday, 14 May 2013 1:09pm
ASPIRE2025 – an interdisciplinary group of tobacco control researchers – conducts research that informs and supports the government’s goal of creating a tobacco-free New Zealand by 2025.
Tuesday, 14 May 2013 1:22pm
Soldier, surgeon, academic - Associate Professor Lieutenant Colonel Dr Darryl Tong is combining all three roles for his PhD on face-and-jaw surgery in the context of warfare.
Tuesday, 14 May 2013 12:22pm
Cancer is the most significant cause of death in New Zealand, likely to affect one in three people at some stage in their lifetime, and accounts for around 30 per cent of all deaths. While there has been a steady improvement in survival rates for many cancers over the last two decades – largely because of early detection and treatment – researchers at the University of Otago, Wellington believe significant further progress can be made in reducing cancer mortality.
Tuesday, 14 May 2013 9:24am
New Zealand has the highest rates of bowel cancer in the world. Fortunately, the University of Otago is at the forefront of cancer research and new findings to bring these figures down.
Tuesday, 14 May 2013 10:00am
Common children’s games have been shown to help hyperactive children learn better self-control and may provide a longer-lasting treatment for ADHD.
Tuesday, 14 May 2013 12:59pm
Over the last decade Professor Philippa Howden-Chapman has repeatedly drawn attention to the detrimental health and social effects of low-quality housing and fragmented policy in housing, cities and energy.
Tuesday, 14 May 2013 2:59pm
The University of Otago hosts two of the most significant longitudinal studies in the world – the Dunedin Multidisciplinary Health and Development Study and the Christchurch Health and Development Study.
Tuesday, 14 May 2013 2:58pm
In 1977 Fergusson signed up more than 1,200 families to be part of a new longitudinal study, running parallel to the Dunedin Multidisciplinary Health and Development Study. Today they are regarded as among the best longitudinal studies in the world.
Tuesday, 14 May 2013 1:02pm
With a suite of novel protein biomarkers patented in areas of unmet clinical need, the Christchurch Heart Institute is helping to save lives, time and money.